Befotrik T 1000mg/125mg Injection
Marketer
Blubell Pharma
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Befotrik T 1000mg/125mg Injection
Tribekta 1000mg/125mg Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism halts microbial proliferation, preventing infection spread. Administration must be strictly under a physician's guidance; missed doses should be avoided. Complete the prescribed course, regardless of symptom improvement; premature cessation may compromise efficacy. Nausea, vomiting, diarrhea, and indigestion are possible side effects; escalating symptoms necessitate immediate medical attention. Seek immediate help for allergic reactions (rash, itching, swelling, breathing difficulty). Disclose all current medications to your doctor before use, especially if pregnant or breastfeeding. Alcohol should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration are crucial for recovery. Your doctor may order tests to monitor the medication's effects.
Uses of Befotrik T 1000mg/125mg Injection
Infections caused by bacteria
Major Benefits of Befotrik T 1000mg/125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strongly discouraged.
Common Side effects of Befotrik T 1000mg/125mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Befotrik T 1000mg/125mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Befotrik T 1000mg/125mg Injection works:
Ceftriaxone/Tazobactum injection (Befotrik T 1000mg/125mg) unites a cephalosporin antibiotic (Ceftriaxone) with a beta-lactamase inhibitor (Tazobactum). Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their growth. Tazobactum counteracts bacterial resistance mechanisms, thus bolstering Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Befotrik T 1000mg/125mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Befotrik T (1000mg/125mg) is typically regarded as safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Befotrik T 1000mg/125mg Injection necessitates prudence during lactation. Breastfeeding is advised against until maternal treatment concludes and the medication is fully cleared from the mother's system.
DrivingUNSAFE
Administration of Befotrik T 1000mg/125mg Injection can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Befotrik T 1000mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Befotrik T 1000mg/125mg Injection cautiously, potentially requiring dosage modification. Physician consultation is advised. Dosage alteration for Befotrik T 1000mg/125mg Injection is unnecessary in individuals with mild to moderate liver dysfunction.
What if you forget to take Befotrik T 1000mg/125mg Injection :
Omit a scheduled Befotrik T 1000mg/125mg Injection? Seek your physician's advice.
Facts to Know About Befotrik T 1000mg/125mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Treatment Category | Drugs to combat infection |
3,018 People bought this recently